EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nano-Encapsulation of Herbal Alkaloids for Targeted Anti-Cancer Delivery

Aatqa Rauf, Zahoor Islam, Fazal Hadi, Hajra Afeera Hamid, Afshan Pervaiz, Muhammad Azhar Sherkheli

Journal of Health, Wellness and Community Research · 30.03.2026 · 1-13

DOI: 10.61919/4t879b92 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Health, Wellness and Community Research, online erschienen am 30.03.2026. Verfasst von Aatqa Rauf und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Herbal alkaloids have potential cytotoxic activity but may be limited by poor solubility, restricted bioavailability, and rapid release.

Objective

To prepare and characterize PLGA–chitosan nanoparticles containing berberine and piperine and compare the release and MCF-7 cytotoxicity of free and nanoencapsulated berberine.

Methods

In this in vitro experimental study, blank, berberine-loaded, piperine-loaded, and combined berberine–piperine nanoparticles were prepared by modified solvent evaporation. Particle size, polydispersity index, zeta potential, encapsulation efficiency, and drug loading were evaluated. Berberine release was assessed for up to 48 hours, and MCF-7 metabolic viability was measured by MTT assay after 48-hour exposure.

Results

Berberine-loaded nanoparticles had a particle size of 156.8 ± 5.6 nm, zeta potential of +24.7 ± 2.1 mV, encapsulation efficiency of 82.6 ± 3.4%, and drug loading of 14.8 ± 1.2%. At 4 and 24 hours, cumulative release was 34.5% and 76.4% from nanoparticles compared with 66.8% and >94% from free berberine. At 100 µg/mL, MCF-7 viability was 21.5 ± 2.8% with nanoencapsulated berberine and 39.7 ± 3.6% with free berberine. The reported IC₅₀ values were 38.7 and 56.4 µg/mL, respectively.

Conclusion

Nanoencapsulation modified berberine release and was associated with lower MCF-7 metabolic viability under the tested in vitro conditions. Verification of the source data and further selectivity, mechanistic, and preclinical studies are required

Zitieren

APA

Rauf, A., Islam, Z., Hadi, F., Hamid, H. A., Pervaiz, A., & Sherkheli, M. A. (2026). Nano-Encapsulation of Herbal Alkaloids for Targeted Anti-Cancer Delivery. Journal of Health, Wellness and Community Research, 1-13. https://doi.org/10.61919/4t879b92

Vancouver

Rauf A, Islam Z, Hadi F, Hamid HA, Pervaiz A, Sherkheli MA. Nano-Encapsulation of Herbal Alkaloids for Targeted Anti-Cancer Delivery. Journal of Health, Wellness and Community Research. 2026:1-13. doi:10.61919/4t879b92

BibTeX
@article{Rauf2026,
  author = {Rauf, Aatqa and Islam, Zahoor and Hadi, Fazal and Hamid, Hajra Afeera and Pervaiz, Afshan and Sherkheli, Muhammad Azhar},
  title = {Nano-Encapsulation of Herbal Alkaloids for Targeted Anti-Cancer Delivery},
  journal = {Journal of Health, Wellness and Community Research},
  year = {2026},
  pages = {1--13},
  doi = {10.61919/4t879b92}
}
Kostenlos starten →